Skip to main content

Optimizing Early-Stage Oncology: TFS’s Strategic Approach to a Dose Escalation and Expansion Phase I Trial

Discover how a U.S. biotech company partnered with a specialized CRO to manage a Phase I oncology trial for a new treatment targeting advanced epithelial tumors. The collaboration covered regulatory consulting, site identification, clinical monitoring, and other services to optimize dose escalation and expansion phases. The CRO’s expertise streamlined operations, ensuring efficiency and adherence to regulatory standards.

What You’ll Learn:

  • How a specialized study team handles seamless trial execution & complex procedures effectively
  • The importance of proactive site selection, including a backup site, for enrollment speed & risk reduction
  • How prompt data reviews & safety updates allow for timely recruitment & study completion
  • The impact of skillful management on slot allocation, patient tracking, & data cleaning

Learn more about our related services and resources:

TFS Oncology & Hematology

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Oncology & Hematology Expertise

Top Contract Research Organizations for Oncology in 2025
Top Contract Research Organizations for Oncology in 2025
Top Contract Research Organizations for Oncology in 2025Article

Top Contract Research Organizations for Oncology in 2025

Learn how these top CROs are advancing cancer research with innovative trial designs, specialized expertise, and cutting-edge technology.
Top 10 Contract Research Organizations (CROs) in 2025
Top 10 CROs to watch in 2025
Top 10 Contract Research Organizations (CROs) in 2025Article

Top 10 Contract Research Organizations (CROs) in 2025

Discover the top 10 CROs in 2025. Learn about industry leaders in clinical trials, technology adoption, & global healthcare solutions.